Login / Signup

Long-Term Management of Generalised Anxiety Disorder with Low-Dose Continuous Infusions of Flumazenil: A Case Series.

Alexander T GalloStephen AddisVlad MartynHishani RamanathanGrace K WilkersonSean D HoodHans StampferGary K Hulse
Published in: Behavioral sciences (Basel, Switzerland) (2022)
Data suggest that low-dose continuous flumazenil infusion manages GAD symptoms and is safe. Although these results are promising, future randomised control trials are required to confirm these results.
Keyphrases
  • low dose
  • high dose
  • clinical trial
  • open label
  • electronic health record
  • current status
  • study protocol
  • double blind
  • big data
  • randomized controlled trial